Diabetic Retinopathy Study (DRS)
NCT00000160 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2006-06-02
Summary
To determine whether photocoagulation helps prevent severe visual loss from proliferative diabetic retinopathy.
To determine whether a difference exists in the efficacy and safety of argon versus xenon photocoagulation for proliferative diabetic retinopathy.
Conditions
Interventions
- PROCEDURE
-
Xenon Photocoagulation
- PROCEDURE
-
Argon Photocoagulation
- PROCEDURE
-
Photocoagulation
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1972-01-31
More Related Trials
-
Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR
NCT04103671 ·Status: RECRUITING ·Phase: NA
-
New Pattern of Retinal Laser Treatment for PDR
NCT07315802 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Treating Early Stage Diabetic Retinopathy
NCT05132660 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG
NCT04117022 ·Status: UNKNOWN ·Phase: NA
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Blood Factors and Diabetic Retinopathy
NCT00005761 ·Status: COMPLETED
-
Pharmacological Intervention in Diabetic Retinopathy
NCT00619034 ·Status: COMPLETED ·Phase: NA
-
Assessment of EyeArt Performance With Retinal Imaging Devices
NCT04302012 ·Status: COMPLETED
-
Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
NCT00411333 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy
NCT03633266 ·Status: UNKNOWN ·Phase: NA
-
Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
NCT06582472 ·Status: RECRUITING
-
The Diabetic Retinopathy Screening, Prevention and Control Program
NCT04240652 ·Status: RECRUITING
-
Severe Proliferative Diabetic Retinopathy
NCT01115257 ·Status: COMPLETED ·Phase: NA
-
Diabetes PRP and OCT
NCT01928550 ·Status: COMPLETED
-
Anti-VEGF Treatment for Prevention of PDR/DME
NCT02634333 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
NCT03112005 ·Status: COMPLETED
-
Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
NCT03078231 ·Status: COMPLETED
-
Study on Exosome Changes in Patients With Proliferative Diabetic Retinopathy
NCT06198543 ·Status: NOT_YET_RECRUITING
-
The Effect of Dopamine on Diabetic Retinopathy
NCT02706977 ·Status: COMPLETED ·Phase: PHASE1
-
A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
NCT02963441 ·Status: COMPLETED
-
Combined Triple Therapy in Diabetic Retinopathy (DRP)
NCT00806169 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
NCT01918371 ·Status: COMPLETED
-
Study of Natural Course Progression of Diabetic Retinopathy
NCT06269419 ·Status: RECRUITING
-
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
NCT02307110 ·Status: COMPLETED ·Phase: NA
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED